Treatment of high-risk gestational trophoblastic neoplasia with etoposide, methotrexate, actinomycin D, cyclophosphamide, and vincristine chemotherapy*

By Escobar P.F.   Lurain J.R.   Singh D.K.   Bozorgi K.   Fishman D.A.  

Gynecologic Oncology, Vol. 91, Iss. 3, 2003-12 ,pp. : 552-557

Elsevier

Access to resources Recommend Favorite

The Management of Gestational Trophoblastic Tumors with Etoposide, Methotrexate, and Actinomycin D

By Soto-Wright V.   Goldstein D.P.   Bernstein M.R.   Berkowitz R.S.  

Gynecologic Oncology, Vol. 64, Iss. 1, 1997-01 ,pp. : 156-159

Elsevier

Access to resources Recommend Favorite

Management of Low-Risk Gestational Trophoblastic Tumors with Etoposide (VP16) in Patients Resistant to Methotrexate

By Mangili G.   Garavaglia E.   Frigerio L.   Candotti G.   Ferrari A.  

Gynecologic Oncology, Vol. 61, Iss. 2, 1996-05 ,pp. : 218-220

Academic Press

Access to resources Recommend Favorite

Combination Chemotherapy with Etoposide, Cisplatin, and Doxorubicin in Mixed Mullerian Tumors of the Adnexa

By Cass I.   Resnik E.   Chambers J.T.   Chambers S.K.   Carcangiu M.L.   Kohorn E.I.   Schwartz P.E.  

Gynecologic Oncology, Vol. 61, Iss. 3, 1996-06 ,pp. : 309-314

Academic Press

Access to resources Recommend Favorite

Risk Factors for the Prediction of Treatment Failure in Gestational Trophoblastic Tumors Treated with EMA/CO Regimen

By Kim S.J.   Bae S.N.   Kim J.H.   Kim C.J.   Jung J.K.  

Gynecologic Oncology, Vol. 71, Iss. 2, 1998-11 ,pp. : 247-253

Elsevier

Access to resources Recommend Favorite